Journal
BLOOD
Volume 97, Issue 4, Pages 1023-1026Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.V97.4.1023
Keywords
-
Categories
Funding
- NCI NIH HHS [CA34233] Funding Source: Medline
- NHLBI NIH HHS [HL33811] Funding Source: Medline
- NIDA NIH HHS [DA06596] Funding Source: Medline
Ask authors/readers for more resources
Hepatitis C virus (HCV)-associated B cell lymphomas were previously shown to express a restricted repertoire of immunoglobulin V-H and V-L genes, V(H)1-69 and V(K)A27, respectively. Although this suggests a role for antigen selection in the pathogenesis of these lymphomas, the driving antigen involved in the clonal expansion has not been identified. B cell response to a viral antigen, the HCV envelope glycoprotein 2 (E2), was analyzed in an asymptomatic HCV-infected patient. Single B cells, immortalized as hybridomas and selected for binding E2, were analyzed for their V gene usage. Sequences of these V region genes demonstrated that each hybridoma expressed unique V-H and V-L genes. Remarkably, these anti-E2 hybridomas preferentially used the V(H)1-69 gene. Analysis of replacement to silent mutation ratios indicated that the genes underwent somatic mutation and antigenic selection. In a separate report, human anti-E2 antibodies were also shown to express the same V-H gene. These data strengthen the hypothesis that the HCV-associated lymphomas are derived from clonally expanded B cells stimulated by HCV. (C) 2001 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available